Showing results (221-230 of 251) with videos related to

Sort By:
Pageof 26
Acta Gastro-Enterologica Belgica|December 15, 2020
Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi methodP-J Cuyle, K Geboes, S Carton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2016
ESMO consensus guidelines for the management of patients with metastatic colorectal cancerE Van Cutsem, A Cervantes, R Adam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2018
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300Y-J Bang, E Yañez Ruiz, E Van Cutsem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2013
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)R A Popescu, R Schäfer, R Califano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2016
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized studyS Faivre, P Niccoli, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2018
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III studyT Yoshino, D C Portnoy, R Obermannová, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
European screening platform for EORTC clinical trials in advanced colorectal cancer 'SPECTAcolor'G Folprecht, M Morfouace, M Collienne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2015
A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trialC S Fuchs, S Azevedo, T Okusaka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2009
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008C Verslype, E Van Cutsem, M Dicato, et al.
Virchows Archiv : an International Journal of Pathology|September 20, 2008
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance programJ H J M van Krieken, A Jung, T Kirchner, et al.
Pageof 26